CDl3/APN与宫颈癌的关系
摘要
CDl3/APNfamino—peptidase N APN)是一种将氨基酸从寡肽N末端切除的膜结合糖蛋白(氨基肽酶N),属于结合锌的金属蛋白酶超家族,其正常功能是在体内通过单一机制或多个机制协同作用参与病理生理过程,主要包括蛋白水解酶酶切作用,作为信号分子参与信号转导,作为细胞表面受体等机制发挥作用。
出处
《中国急救复苏与灾害医学杂志》
2011年第7期654-655,共2页
China Journal of Emergency Resuscitation and Disaster Medicine
参考文献19
-
1Riemann D, Kehlen A, Langner J. CD13-not just a marker in leukemia typing. Immunol Today, 1999,20(2):83-88.
-
2Bordessoule D, Jones M, Gatter KC, et al. Immunohistological patterns of myeloid antigens: tissue distribution of CD13, CD14, CD16, CD31, CD36, CD65, CD66 and CD67. Br J Haematol, 1993,83(3):370-383.
-
3Alliot F, Rutin J, Leenen PJ, et al. Pericytes and periendothelial cells of brain parenchyma vessels co-express aminopeptidase N, aminopeptidase A, and nestin. J Neuros/:i Res,1999,58(3):367-378.
-
4Ashmun RA, Look AT. Metalloprotease activity of CD13/aminopeptidase N on the surface of human myeloid cells. Blood, 1990,75(2):462-469.
-
5Riemann D, Kehlen A, Langner J. CD13-not just a marker in leukemia typing. Immuanl Today, 1999,20(2): 83-88.
-
6Shimizu T, Tan i K, Hase K, et al. CD13 / aminopeptidase N-induced lymphocyte involvement in inflamed joints of patients with rheumatoid arthritis. Arthritis Rheum,2002,46(9): 2330-2338.
-
7Bonewia A, Zelus BD, Wentworth DE, et al. Identification of areceptor-binding domain of the spike glycoprotein of Human coronavirus HCoV-229. J Virel, 2003,77(4): 2530-2538.
-
8Breslin JJ, Mork I, Smith MK, et al. Human coronavirus 229E: receptor binding domain and neutralization by soluble receptor at 37 degrees C. J Virel, 2003,77(7) :4435-4438.
-
9Kramer W, Girbig F, Corsiere D, et ai. Aminopeptidase N (CD13) is a molecular target of the cholesterol absorption inhibitor ezetimibe in the enterocyte brush border membrane. J Bid Chem, 2005,280(2):1306-1320.
-
10Saiki I, Fujii H, Yoneda J, et al. Role of aminopeptidase N (CD13) in tumor-cell invasion and extracellular matrix degradation. Int J Cancer, 1993,54(1):137-143.
二级参考文献26
-
1[1]Folkman J.Tumor angiogenesis:therapeutic implications[J].N Engl J Med,1971,285:1182-1186.
-
2[2]Collins I,Workman P.New appmachm to molecular cancer therapeutics[J].Nat Chem Biol,2006,2:689-700.
-
3[3]Ferrara N,Hillan KJ,Gerber HP,et al.Discovery and development of bevacizumab,an anti-VEGF antibody for treating cancer[J].Nat Rev Drug Discov,2004,3:391-400.
-
4[4]Wang Y,Fei D,Vandedaan M,et al.Biological activity of bevacizumab,a humanized anti-VEGF antibody in vitro[J].Angiogenesis,2004,7:335-345.
-
5[5]Keiko Shibuya,Ritsuko Komaki,Tomoaki Shintani,et al.Targeted therapy against VEGFR and EGFR with ZD6474 enhances the therapeutic efficacy of irradiation in an orthotopic model of human non -small-cell lung cancer[J].Int J f Radia Oncol Biol Phys,69:1534-1543.
-
6[6]Dings RP,Chen X,Hellebrekers DM,et al.Design of nonpeptidic topomimeties of antiangiogenlc proteins with antitumor activities[J].J Natl Cancer Inst,2006,98:932-936.
-
7[7]Nakamura K,Taguchi E,Miura T,et al.KRN951,a highly potent inhibitor of vascular endothelial growth factor receptor tyrosine,has antitumor activities and affects functional vascular properties[J].Urol Oncol,2007,25:359-360.
-
8[8]Feng-Yao Tang,En-Pei Isabel Chiang,Chung-Jin Shih.Green tea catechin inhibits ephrin-A1-mediated cell migration and angiogenesis of human umbilical vein endothelial cells[J].J Nutr,2007,6:391-399.
-
9[9]Yu Y,Moulton KS,Khan MK,et al.Eselectin is required for the antiangiogenic activity of endostatm[J].Proe Nail Acad Sei USA,2004,101:8005-8010.
-
10[10]Van Beijnum JR,Griffioen AW.In silico analysis of angiogenesis associated gene expression identifies angiogenic stage related profiles[J].Biochim Biophys Acta,2005,1755:121-134.
共引文献4
-
1王婉钢,朱秀华,程刚英.肿瘤血管生成抑制剂临床研究现状[J].中国药师,2010,13(7):1038-1041.
-
2杨彩虹,张雪玉,李丽芳,张咏梅,吴蔚.VEGF-C及其受体基因在宫颈鳞癌中的表达[J].宁夏医学杂志,2011,33(7):579-581.
-
3王倩,许尤琪.中西医抗血管生成治疗大肠癌研究进展[J].现代肿瘤医学,2013,21(5):1146-1148.
-
4杨雪峰,邓冬雪,张桃,宁伟伟,郑兴斌,谢铭.龙葵碱联合VEGF抗体对人结肠癌鸡胚移植模型血管生成的影响[J].重庆医学,2016,45(3):342-344. 被引量:10
-
1姚雪伟.人工破膜结合体位指导在产程中的应用[J].浙江医学,2013,35(6):481-482. 被引量:2
-
2于淼,邓成艳.抗苗勒管激素评估卵巢储备功能的临床应用[J].中国医学科学院学报,2009,31(1):114-119. 被引量:4
-
3产科 其他[J].中国医学文摘(计划生育妇产科学),2006,25(6):429-430.
-
4顾玲珠,吴珊珊,李进.妊娠期糖尿病合并冠心病患者hs-CRP、MMP-2、MMP-9、TIMP-1测定的临床意义[J].浙江临床医学,2014,16(4):578-579. 被引量:1
-
5宗利丽.子宫内膜异位症分子机制研究进展[J].国外医学(妇产科学分册),2001,28(5):276-279. 被引量:8
-
6生理分娩(正常分娩)[J].国外科技资料目录(医药卫生),2002(3):88-88.
-
7石少权,熊秀梅,丘彦.生长分化因子-9与卵泡发育[J].国外医学(计划生育分册),2005,24(1):24-27. 被引量:1
-
8王海霞.基质碱金属蛋白酶(MMPs)与早产[J].中国保健营养(临床医学学刊),2010,19(8):117-119. 被引量:1
-
9王洋,冯伟华.二肽基肽酶4抑制剂治疗多囊卵巢综合征合并糖代谢异常患者同型半胱氨酸及免疫细胞水平的影响分析[J].山西医药杂志,2016,45(1):58-60. 被引量:2
-
10苏叶青,李红梅.MMP-9与妊娠期高血压疾病关系的研究进展[J].中外医疗,2012,31(26):179-180. 被引量:3